PET imaging of innate immune activation using 11C radiotracers targeting GPR84

Kalita, M. et al. (2023) PET imaging of innate immune activation using 11C radiotracers targeting GPR84. JACS Au, 3(12), pp. 3297-3310. (doi: 10.1021/jacsau.3c00435) (PMID:38155640) (PMCID:PMC10751761)

[img] Text
316114.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

8MB

Abstract

Chronic innate immune activation is a key hallmark of many neurological diseases and is known to result in the upregulation of GPR84 in myeloid cells (macrophages, microglia, and monocytes). As such, GPR84 can potentially serve as a sensor of proinflammatory innate immune responses. To assess the utility of GPR84 as an imaging biomarker, we synthesized 11C-MGX-10S and 11C-MGX-11Svia carbon-11 alkylation for use as positron emission tomography (PET) tracers targeting this receptor. In vitro experiments demonstrated significantly higher binding of both radiotracers to hGPR84-HEK293 cells than that of parental control HEK293 cells. Co-incubation with the GPR84 antagonist GLPG1205 reduced the binding of both radiotracers by >90%, demonstrating their high specificity for GPR84 in vitro. In vivo assessment of each radiotracer via PET imaging of healthy mice illustrated the superior brain uptake and pharmacokinetics of 11C-MGX-10S compared to 11C-MGX-11S. Subsequent use of 11C-MGX-10S to image a well-established mouse model of systemic and neuro-inflammation revealed a high PET signal in affected tissues, including the brain, liver, lung, and spleen. In vivo specificity of 11C-MGX-10S for GPR84 was confirmed by the administration of GLPG1205 followed by radiotracer injection. When compared with 11C-DPA-713-an existing radiotracer used to image innate immune activation in clinical research studies-11C-MGX-10S has multiple advantages, including its higher binding signal in inflamed tissues in the CNS and periphery and low background signal in healthy saline-treated subjects. The pronounced uptake of 11C-MGX-10S during inflammation, its high specificity for GPR84, and suitable pharmacokinetics strongly support further investigation of 11C-MGX-10S for imaging GPR84-positive myeloid cells associated with innate immune activation in animal models of inflammatory diseases and human neuropathology.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Milligan, Professor Graeme and Marsango, Dr Sara
Creator Roles:
Marsango, S.Data curation, Formal analysis
Milligan, G.Resources, Supervision
Authors: Kalita, M., Park, J. H., Kuo, R. C., Hayee, S., Marsango, S., Straniero, V., Alam, I. S., Rivera-Rodriguez, A., Pandrala, M., Carlson, M. L., Reyes, S. T., Jackson, I. M., Suigo, L., Luo, A., Nagy, S. C., Valoti, E., Milligan, G., Habte, F., Shen, B., and James, M. L.
College/School:College of Medical Veterinary and Life Sciences > School of Molecular Biosciences
Journal Name:JACS Au
ISSN:2691-3704
ISSN (Online):2691-3704
Copyright Holders:Copyright © 2023 The American Chemical Society
First Published:First published in JACS Au 3:(12)3297–3310
Publisher Policy:Reproduced under a Creative Commons licence

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
305987IPA Responsive Mode BBSRC Resubmission GPR84Graeme MilliganBiotechnology and Biological Sciences Research Council (BBSRC)BB/T000562/1School of Molecular Biosciences